Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Detalles Bibliográficos
Main Authors:	Sinadinos, A, Sergijenko, A, Meng, C, Gamlin, T, Hyde, S, Gill, DR, Griesenbach, U, Alton, EWFW
Formato:	Conference item
Idioma:	English
Publicado:	Cell Press 2021

Títulos similares

Development of protocols for mouse GLP-toxicology studies
por: Sinadinos, A, et al.
Publicado: (2020)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
por: Sinadinos, A, et al.
Publicado: (2021)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
por: Sergijenko, A, et al.
Publicado: (2021)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
por: Sergijenko, A, et al.
Publicado: (2020)

Gene therapy for respiratory diseases; progress and a changing context
por: Alton, EWFW, et al.
Publicado: (2020)

Low titer lentiviral transgenesis in rodents with simian immundeficiency virus vector
por: Balázs Bender, et al.
Publicado: (2013-09-01)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
por: Tan, T, et al.
Publicado: (2018)

Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
por: Helena Lund-Palau, et al.
Publicado: (2022-06-01)

Lung-targeting lentiviral vector for passive immunisation against influenza
por: Tan, TK, et al.
Publicado: (2020)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
por: Gelinas, J, et al.
Publicado: (2013)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
por: Gélinas, J, et al.
Publicado: (2017)

Rapid determination of rSIV.F/HN lentiviral vector titre
por: Conway, CC, et al.
Publicado: (2020)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
por: Sinadinos, A, et al.
Publicado: (2020)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
por: Ashworth, R, et al.
Publicado: (2018)

Lentiviral Vector Bioprocessing
por: Christopher Perry, et al.
Publicado: (2021-02-01)

Production of lentiviral vectors
por: Otto-Wilhelm Merten, et al.
Publicado: (2016-01-01)

Advances of Lentiviral Vectors
por: Fanrong MENG, et al.
Publicado: (2014-12-01)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
por: Munday, R, et al.
Publicado: (2018)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
por: Munday, R, et al.
Publicado: (2019)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
por: Antepowicz, A, et al.
Publicado: (2021)

The very stable lentiviral vector
por: Gwendolyn K. Binder, et al.
Publicado: (2024-03-01)

Special Issue “Lentiviral Vectors”
por: Yasuhiro Takeuchi
Publicado: (2022-07-01)

The Inside Out of Lentiviral Vectors
por: Stéphanie Durand, et al.
Publicado: (2011-02-01)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
por: Agata Antepowicz, et al.
Publicado: (2021-08-01)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
por: Griesenbach, U, et al.
Publicado: (2011)

Enhanced lentiviral production through rational design of mammalian host cells
por: Hyde, S, et al.
Publicado: (2016)

Lentiviral Vectors for Ocular Gene Therapy
por: Yvan Arsenijevic, et al.
Publicado: (2022-07-01)

Comparison of lentiviral vector titration methods
por: Debyser Zeger, et al.
Publicado: (2006-07-01)

An Improved Protocol for the Production of Lentiviral Vectors
por: Logan Y. Brown, et al.
Publicado: (2020-12-01)

Rev-dependent lentiviral expression vector
por: Beddall Margaret H, et al.
Publicado: (2007-02-01)

Effective gene therapy with nonintegrating lentiviral vectors.
por: Yáñez-Muñoz, R, et al.
Publicado: (2006)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
por: Inès Dufait, et al.
Publicado: (2012-01-01)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
por: Massimo Conese, et al.
Publicado: (2010-01-01)

Lentiviral Vector Gene Transfer to Porcine Airways
por: Patrick L Sinn, et al.
Publicado: (2012-01-01)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
por: Munday, RJ, et al.
Publicado: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
por: Munday, RJ, et al.
Publicado: (2022)

Moving lentiviral-based gene therapy into a first-in-man CF trial
por: Griesenbach, D, et al.
Publicado: (2015)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
por: Alton, E, et al.
Publicado: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
por: Alton, E, et al.
Publicado: (2014)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
por: Munday, RJ, et al.
Publicado: (2022)